Medibank Private Ltd. (AU:MPL)
ASX:MPL
Want to see AU:MPL full AI Analyst Report?
MPL Stock Chart & Stats
AU$4.67
-AU$0.01(-0.26%)
At close: 4:00 PM EST
AU$4.67
-AU$0.01(-0.26%)
Day’s Range― - ―
52-Week RangeAU$4.06 - AU$5.31
Previous CloseN/A
Volume3.70M
Average Volume (3M)5.96M
Market Cap
AU$13.66B
Enterprise ValueAU$13.25B
Total Cash (Recent Filing)AU$453.30M
Total Debt (Recent Filing)AU$481.30M
Price to Earnings (P/E)29.7
Beta0.21
Next Earnings
Aug 20, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend Yield3.73%
Share Statistics
EPS (TTM)0.17
Shares Outstanding2,754,003,200
10 Day Avg. Volume5,399,409
30 Day Avg. Volume5,964,521
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)5.95
Price to Sales (P/S)1.63
P/FCF Ratio37.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$5.00Price Target Upside7.07% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)0.23
Revenue Forecast (FY)AU$9.15B
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet And High ROEVery low leverage and consistently strong ROE indicate durable financial resilience. Low debt-to-equity (<0.10) preserves flexibility for underwriting volatility and regulatory shocks, supports dividends and M&A, and reduces refinancing risk over the next 2–6 months.
Medibank Health: Strong Growth And Margin ImprovementRapid, profitable expansion of Medibank Health diversifies earnings away from pure insurance underwriting. Double-digit revenue and profit growth with improving margins creates a structurally higher-margin business line that can sustainably lift group profitability and provide longer-term revenue optionality.
Strong Capital Position And Dividend ContinuityAbove-target capital ratios and an increased interim dividend signal conservative capital management and capacity to support growth or absorb shocks. Holding excess PCA coverage and ability to issue Tier-2 debt provide durable funding optionality for M&A or investment over the medium term.
Bears Say
Volatile Free Cash Flow And Weaker Operating CashA sharp FCF decline and operating cash volatility reduce confidence in cash convertibility of earnings. Lower and unpredictable cash generation constrains organic investment, makes dividends or M&A more capital-sensitive, and raises reliance on capital markets or reserves.
Revenue-mix Shift Toward Lower-tier ProductsA sustained shift to lower-tier policies reduces revenue per policy and compresses top-line growth unless offset by pricing or product redesign. Structural consumer behavior and aggregator competition can keep mix pressure persistent, limiting margin expansion from core premiums.
Claims Inflation And Adverse Utilization DynamicsRising claims and volatile hospital utilization create underwriter risk and margin pressure. Persistent extras inflation and unpredictable utilization trends require sustained pricing discipline, risk equalization management, and provider cost control to protect underwriting profits over the medium term.
Medibank Private News
MPL FAQ
What was Medibank Private Ltd.’s price range in the past 12 months?
Medibank Private Ltd. lowest share price was AU$4.06 and its highest was AU$5.31 in the past 12 months.
What is Medibank Private Ltd.’s market cap?
Medibank Private Ltd.’s market cap is AU$13.66B.
When is Medibank Private Ltd.’s upcoming earnings report date?
Medibank Private Ltd.’s upcoming earnings report date is Aug 20, 2026 which is in 68 days.
How were Medibank Private Ltd.’s earnings last quarter?
Medibank Private Ltd. released its earnings results on Feb 18, 2026. The company reported AU$0.108 earnings per share for the quarter, missing the consensus estimate of AU$0.11 by -AU$0.002.
Is Medibank Private Ltd. overvalued?
According to Wall Street analysts Medibank Private Ltd.’s price is currently Undervalued.
Does Medibank Private Ltd. pay dividends?
Medibank Private Ltd. pays a Semiannually dividend of AU$0.083 which represents an annual dividend yield of 3.73%. See more information on Medibank Private Ltd. dividends here
What is Medibank Private Ltd.’s EPS estimate?
Medibank Private Ltd.’s EPS estimate is 0.12.
How many shares outstanding does Medibank Private Ltd. have?
Medibank Private Ltd. has 2,754,003,200 shares outstanding.
What happened to Medibank Private Ltd.’s price movement after its last earnings report?
Medibank Private Ltd. reported an EPS of AU$0.108 in its last earnings report, missing expectations of AU$0.11. Following the earnings report the stock price went down -5.638%.
Which hedge fund is a major shareholder of Medibank Private Ltd.?
Currently, no hedge funds are holding shares in AU:MPL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medibank Private Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
66.92%
12-Months-Change
Fundamentals
Return on Equity
19.79%
Trailing 12-Months
Asset Growth
9.08%
Trailing 12-Months
Company Description
Medibank Private Ltd.
Medibank Private Limited (MPL.AX) is an Australian firm offering private health insurance alongside a variety of health services. The company operates through two primary divisions. Its Health Insurance division provides a comprehensive suite of private health insurance policies, encompassing coverage for hospital treatments and supplementary benefits for services like dental, optical, and physiotherapy. This division also caters to international visitors and students with specific insurance products, all underwritten by the Medibank and ahm brands. The Medibank Health division delivers health management programs, in-home care solutions, and telehealth services, primarily serving governmental and corporate clients. Furthermore, this segment handles the distribution of travel, life, and pet insurance products. Established in 1976, Medibank Private Limited is headquartered in Docklands, Australia.
MPL Company Deck
MPL Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed positive operational momentum and strategic progress: group operating profit rose 6%, Medibank Health delivered strong double-digit revenue and profit growth, policyholder growth improved and the company completed a transformative primary care acquisition while maintaining a strong capital position and lifting the interim dividend. Headwinds exist—expense inflation, a revenue-mix shift toward lower-tier products, elevated claims dynamics in extras, negative hospital utilization (partly COVID-driven), lower investment income and competitive pressure from aggregators—but management presented mitigation plans, unchanged guidance ranges, and clear capacity to invest further in health businesses. Overall, the positives (earnings growth, Medibank Health acceleration, M&A scale, capital strength and customer engagement) outweigh the manageable near-term challenges.View all AU:MPL earnings summariesMPL Stock 12 Month Forecast
Average Price Target
AU$5.00
▲(7.07% Upside)
Technical Analysis
Options Prices
Currently, No data available
---